Building efficient, effective, locally sensitive solutions for dementia careOctober 12, 2007Indianapolis Discovery Network for Dementia INDIANAPOLIS - Dementia is a growing burden for society, propelling patients and caregivers to increasingly use the health-care system. A year ago, local researchers, health-care professionals, and community advocates came together to form the Indianapolis Discovery Network for Dementia (IDND) to enhance dementia care in the nation's twelfth largest city. On Oct. 20, IDND will launch RAPID-PC - Recognizing and Assessing the Progression of Cognitive Impairment and Dementia in Primary Care with a summit meeting for researchers, clinicians, nurses, nurse practitioners and physician assistants to share experiences and progress.
The group is drawing upon unique features of the Indianapolis health-care environment, the most wired in the nation, to develop a model which they believe other communities can use to enhance the delivery of dementia care. "If tomorrow we developed a breakthrough in dementia treatment such as a vaccine, it would take 17 years and $800 million for that development to become available as a prescription and it would reach only a fraction of those who could benefit from it. That isn't acceptable," said Malaz Boustani, M.D., M.P.H., an assistant professor of medicine at Indiana University School of Medicine, an Indiana University Center for Aging Research investigator and a Regenstrief Institute research scientist. Dr. Boustani, IDND's chief research officer, bases his estimates on a systematic review of drug development literature. According to Dr. Boustani, in the state of Indiana, which he says is representative of the U.S. as a whole, 60 percent of people with dementia or pre-dementia (also known as mild cognitive impairment) are not recognized as having these conditions when they go to a hospital and 80 percent are not recognized as having dementia or pre-dementia by their primary care physicians. The result is that less than 10 percent receive medications appropriate to their level of cognitive impairment and approximately a quarter receive medications which are inappropriate. "Nationwide, the health-care system is not delivering good dementia care because we have not presented a comprehensive assessment of the biopsychosocial needs of a person with dementia and have not followed up with solutions that are sensitive to local community needs and resources," said Dr. Boustani, who is a geriatrician. Eight out of 10 individuals with dementia living in the community have significant behavioral and/or psychological symptoms that require medical and psychological care. He also notes that caregivers have been largely ignored in spite of the fact that they provide millions of unpaid care hours per year (180 million hours valued at $1.7 trillion in Indiana in 2005) and are hospitalized at a very high rate (24 percent over a six-month period in Indiana). With Rapid-PC, IDND is taking a major step toward its goal of building efficient, effective, locally sensitive solutions for dementia care. Indiana University | |||||||||||||||||||||
|
Related Dementia Current Events and Dementia News Articles Rapid Screening Test Developed to Detect Early Alzheimer's Disease With millions of baby boomers entering late adulthood, the number of patients with Alzheimer's disease (AD) is expected to drastically rise over the next several decades. Caring for the caregiver: Redefining the definition of patient One quarter of all family caregivers of Alzheimer's disease patients succumb to the stress of providing care to a loved one and become hospital patients themselves, according to an Indiana University study published in the November 2008 issue of the Journal of General Internal Medicine. Vitamin B3 reduces Alzheimer's symptoms, lesions An over-the-counter vitamin in high doses prevented memory loss in mice with Alzheimer's disease, and UC Irvine scientists now are conducting a clinical trial to determine its effect in humans. Common epilepsy drug could prevent and treat Alzheimer's disease The team led by UBC Psychiatry Prof. Weihong Song, who is also the Jack Brown and Family Professor and Chair in Alzheimer's Disease at UBC, found that if Valproic Acid (VPA) is used as a treatment in early stages of AD memory deficit is reversed. Drinking alcohol associated with smaller brain volume The more alcohol an individual drinks, the smaller his or her total brain volume, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals. Has a new era of reinstitutionalization in mental health care begun? A retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and the number of psychiatric beds in England 1996-2006. New study proves that pain is not a symptom of arthritis, pain causes arthritis Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism. Study confirms benefit of combination therapy for Alzheimer's disease Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. Inflammatory response to infection and injury may worsen dementia Inflammation in the brain resulting from infection or injury may accelerate the progress of dementia, research funded by the Wellcome Trust suggests. Researchers seeking to identify Alzheimer's risk focus on specific blood biomarker A simple blood test to detect whether a person might develop Alzheimer's disease is within sight and could eventually help scientists in their quest toward reversing the disease's onset in those likely to develop the debilitating neurological condition. More Dementia Current Events and Dementia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||